NCT03484156

Brief Summary

The study aim is to assess the capacity of a technological solution for analyzing older person's functional and cognitive autonomy at home. Results from this study will also be used to elaborate the design of a further larger national multicenter randomized control trial assessing the efficacy of the solution to detect early infra-clinical disability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
7 months until next milestone

First Posted

Study publicly available on registry

March 30, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

July 12, 2019

Status Verified

July 1, 2019

Enrollment Period

1.8 years

First QC Date

June 15, 2017

Last Update Submit

July 11, 2019

Conditions

Keywords

ElderlyFrailtyTele-monitoringDisability

Outcome Measures

Primary Outcomes (1)

  • The occurrence of alerts

    The occurrence of alerts : each alert will be recorded to characterize the number and the pace of alerts during the time of follow-up

    6 months

Secondary Outcomes (1)

  • The relevance of each alert according to the subjective opinion

    6 months

Other Outcomes (3)

  • The occurrence of major clinical events

    6 months

  • The functional autonomy

    6 months

  • The cognitive autonomy

    6 months

Study Arms (1)

Volunteers

EXPERIMENTAL

The Installation of 3PEGASE Sensor in elders volunteers to monitor clinical indicators at home.The instrument is for monitoring functional and cognitive autonomy in frail or disable elderly persons living alone at home. The volunteers will have 70 years old or more, living alone at home, frail of disable (ADL\> or =3) and able to walk by themselves.

Device: Installation of 3PEGASE Sensor

Interventions

Volunteers will be equipped with the 3-PEGASE solution to monitor clinical indicators at home : By assessing older person's autonomy at home and detecting early infra-clinical indicators, the solution could provide relevant clinical parameters to the caregivers and healthcare professionals in order to support the patient's follow-up, and support the detection of preliminary signs of functional loss

Volunteers

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • patient aged 75 or more, living alone at home
  • frail of disable (ADL superior or equal at 3)
  • able to walk by themselves

You may not qualify if:

  • patient presenting a Mini Mental State lower at 16/30 and without a daily intervention from a caregiver
  • non agreement of study participation of patients or the reliable person when appropriate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital, Toulouse

Toulouse, Midi-Pyrenes, 31059, France

Location

CHU Toulouse

Toulouse, 31059, France

Location

Related Publications (1)

  • Piau A, Lepage B, Bernon C, Gleizes MP, Nourhashemi F. Real-Time Detection of Behavioral Anomalies of Older People Using Artificial Intelligence (The 3-PEGASE Study): Protocol for a Real-Life Prospective Trial. JMIR Res Protoc. 2019 Nov 18;8(11):e14245. doi: 10.2196/14245.

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Antoine Piau, MD

    Toulouse CHU

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2017

First Posted

March 30, 2018

Study Start

September 1, 2017

Primary Completion

July 1, 2019

Study Completion

July 1, 2019

Last Updated

July 12, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations